PubMed

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, Cardasis HL, Cusack MP, Dodder NG, Gibson BW, Held JM, Hiltke T, Jackson A, Johansen EB, Kinsinger CR, Li J, Mesri M, Neubert TA, Niles RK, Pulsipher TC, Ransohoff D, Rodriguez H, Rudnick PA, Smith D, Tabb DL, Tegeler TJ, Variyath AM, Vega-Montoto LJ, Wahlander A, Waldemarson S, Wang M, Whiteaker JR, Zhao L, Anderson NL, Fisher SJ, Liebler DC, Paulovich AG, Regnier FE, Tempst P, Carr SA.

Nat Biotechnol. 2009 Jul;27(7):633-41. Epub 2009 Jun 28.PMID: 19561596 [PubMed - indexed for MEDLINE]Related articles

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I.

Lancet Oncol. 2009 Apr;10(4):327-40. Epub 2009 Mar 11.PMID: 19282241 [PubMed - indexed for MEDLINE]Related articles

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.

Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, Gajewski W, Kurman R, Bast RC Jr, Skates SJ.

Gynecol Oncol. 2009 Jan;112(1):40-6. Epub 2008 Oct 12.PMID: 18851871 [PubMed - indexed for MEDLINE]Related articles

Ovarian cancer screening was feasible but did not decrease incidence of index cancer or mortality.

Jacobs I, Skates S, Macdonald N.

West J Med. 2000 Feb;172(2):97. No abstract available. PMID: 18751238 [PubMed - as supplied by publisher]Related articlesFree article

Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.

Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW.

J Thorac Oncol. 2008 Aug;3(8):851-7.PMID: 18670302 [PubMed - indexed for MEDLINE]Related articles

Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.

Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW.

Chest. 2007 Oct;132(4):1239-46. Epub 2007 Jul 23.PMID: 17646232 [PubMed - indexed for MEDLINE]Related articlesFree article

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.

Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT, Bluemke DA, Bowen DJ, Marcom PK, Armstrong DK, Domchek SM, Tomlinson G, Skates SJ, Gatsonis C.

Radiology. 2007 Aug;244(2):381-8.PMID: 17641362 [PubMed - indexed for MEDLINE]Related articlesFree article

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.

Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ, Robinson BW.

Thorax. 2007 Jul;62(7):569-76. Epub 2007 Mar 13.PMID: 17356060 [PubMed - indexed for MEDLINE]Related articles

Pooling of case specimens to create standard serum sets for screening cancer biomarkers.

Skates SJ, Horick NK, Moy JM, Minihan AM, Seiden MV, Marks JR, Sluss P, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):334-41.PMID: 17301268 [PubMed - indexed for MEDLINE]Related articlesFree article

Familial ovarian screening--effective or ineffective?

Jacobs IJ, Mackay J, Menon U, Skates SJ, Rosenthal AN, Fraser L.

Br J Cancer. 2006 Oct 23;95(8):1124; author reply 1126-7. No abstract available. PMID: 17047658 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, Macdonald N, Dawnay A, Jeyarajah A, Bast RC Jr, Oram D, Jacobs IJ.

J Clin Oncol. 2005 Nov 1;23(31):7919-26.PMID: 16258091 [PubMed - indexed for MEDLINE]Related articles

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr.

J Clin Oncol. 2004 Oct 15;22(20):4059-66. Epub 2004 Sep 20.PMID: 15381683 [PubMed - indexed for MEDLINE]Related articles

Blood and urine markers for ovarian cancer: a comprehensive review.

Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW.

Dis Markers. 2004;20(2):53-70. Review. No abstract available. PMID: 15322314 [PubMed - indexed for MEDLINE]Related articles

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.

Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC.

Clin Cancer Res. 2004 May 15;10(10):3474-8.PMID: 15161704 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.

Penson RT, Oliva E, Skates SJ, Glyptis T, Fuller AF Jr, Goodman A, Seiden MV.

Gynecol Oncol. 2004 Apr;93(1):98-106.PMID: 15047220 [PubMed - indexed for MEDLINE]Related articles

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC.

Clin Cancer Res. 2003 Oct 15;9(13):4782-91.PMID: 14581349 [PubMed - indexed for MEDLINE]Related articlesFree article

Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.

Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC.

Clin Cancer Res. 2003 Aug 1;9(8):2904-11.PMID: 12912935 [PubMed - indexed for MEDLINE]Related articlesFree article

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, Jacobs IJ.

J Clin Oncol. 2003 May 15;21(10 Suppl):206s-210s.PMID: 12743136 [PubMed - indexed for MEDLINE]Related articles

Progress in the management of gynecologic cancer: consensus summary statement.

Cannistra SA, Bast RC Jr, Berek JS, Bookman MA, Crum CP, DePriest PD, Garber JE, Koh WJ, Markman M, McGuire WP 3rd, Rose PG, Rowinsky EK, Rustin GJ, Skates SJ, Vasey PA, King L.

J Clin Oncol. 2003 May 15;21(10 Suppl):129s-132s. No abstract available. PMID: 12743127 [PubMed - indexed for MEDLINE]Related articles

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC.

JAMA. 2002 Apr 3;287(13):1671-9.PMID: 11926891 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for ovarian cancer-risk, education, worry: path to appropriate use?

Skates SJ.

Gynecol Oncol. 2002 Apr;85(1):1-2. No abstract available. PMID: 11925112 [PubMed - indexed for MEDLINE]Related articles

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ.

Ann Intern Med. 2001 Sep 18;135(6):393-400.PMID: 11560452 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors influencing serum CA125II levels in healthy postmenopausal women.

Pauler DK, Menon U, McIntosh M, Symecko HL, Skates SJ, Jacobs IJ.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):489-93.PMID: 11352859 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.PMID: 10847254 [PubMed - indexed for MEDLINE]Related articlesFree article

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ.

BJOG. 2000 Feb;107(2):165-9.PMID: 10688498 [PubMed - indexed for MEDLINE]Related articles

Clinical course of stage IV epithelial ovarian cancer.

Penson RT, Skates SJ, Fuller AJ Jr, Seiden MV.

J Clin Oncol. 1999 Oct;17(10):3361-2. No abstract available. PMID: 10506641 [PubMed - indexed for MEDLINE]Related articles

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.

Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ.

Br J Cancer. 1999 Jul;80(10):1644-7.PMID: 10408412 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for ovarian cancer: a pilot randomised controlled trial.

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH.

Lancet. 1999 Apr 10;353(9160):1207-10.PMID: 10217079 [PubMed - indexed for MEDLINE]Related articles

Acetaminophen and risk factors for excess anticoagulation with warfarin.

Eliason BC, Larson W, Singer DE, Skates SJ.

JAMA. 1998 Aug 26;280(8):696-7. No abstract available. Erratum in: JAMA 1999 Jan 6;281(1):37. PMID: 9728633 [PubMed - indexed for MEDLINE]Related articles

The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men.

Lein M, Koenig F, Jung K, McGovern FJ, Skates SJ, Schnorr D, Loening SA.

Br J Urol. 1998 Aug;82(2):231-6.PMID: 9722758 [PubMed - indexed for MEDLINE]Related articles

Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE.

JAMA. 1998 Mar 4;279(9):657-62.PMID: 9496982 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.

Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL.

Ann Intern Med. 1997 Jun 1;126(11):866-73.PMID: 9163287 [PubMed - indexed for MEDLINE]Related articlesFree article

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Hylek EM, Skates SJ, Sheehan MA, Singer DE.

N Engl J Med. 1996 Aug 22;335(8):540-6.PMID: 8678931 [PubMed - indexed for MEDLINE]Related articlesFree article

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

Skates SJ, Xu FJ, Yu YH, Sjövall K, Einhorn N, Chang Y, Bast RC Jr, Knapp RC.

Cancer. 1995 Nov 15;76(10 Suppl):2004-10.PMID: 8634992 [PubMed - indexed for MEDLINE]Related articles

Screening for ovarian cancer.

Carlson KJ, Skates SJ, Singer DE.

Ann Intern Med. 1994 Jul 15;121(2):124-32. Review.PMID: 8017726 [PubMed - indexed for MEDLINE]Related articlesFree article

Changing blood use in the AIDS era: the case of elective hip surgery.

Atlas SJ, Singer DE, Skates SJ.

Transfusion. 1994 May;34(5):386-91.PMID: 8191561 [PubMed - indexed for MEDLINE]Related articles

The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass.

Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR.

JAMA. 1991 Mar 6;265(9):1133-8.PMID: 1995999 [PubMed - indexed for MEDLINE]Related articles

Quantifying the potential benefit of CA 125 screening for ovarian cancer.

Skates SJ, Singer DE.

J Clin Epidemiol. 1991;44(4-5):365-80.PMID: 2010780 [PubMed - indexed for MEDLINE]Related articles

Length of stay in the intensive care unit. Effects of practice guidelines and feedback.

Eagle KA, Mulley AG, Skates SJ, Reder VA, Nicholson BW, Sexton JO, Barnett GO, Thibault GE.

JAMA. 1990 Aug 22-29;264(8):992-7.PMID: 2376892 [PubMed - indexed for MEDLINE]Related articles

Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.

Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ, et al.

Cancer Res. 1989 Dec 15;49(24 Pt 1):7147-52.PMID: 2573426 [PubMed - indexed for MEDLINE]Related articlesFree article

Three-dimensional volumetric assessment of response to treatment: stage I and II diffuse large cell lymphoma of the mediastinum.

Willett CG, Stracher MA, Linggood RM, Miketic LM, Leong JC, Skates SJ, Kushner DC, Jacobson JO.

Radiother Oncol. 1988 Jul;12(3):193-8.PMID: 3175046 [PubMed - indexed for MEDLINE]Related articles

Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.

Willett CG, Linggood RM, Leong JC, Miketic LM, Stracher MA, Skates SJ, Kushner DC.

J Clin Oncol. 1988 May;6(5):819-24.PMID: 3367187 [PubMed - indexed for MEDLINE]Related articles

Adjuvant postoperative radiation therapy for colonic carcinoma.

Willett CG, Tepper JE, Skates SJ, Wood WC, Orlow EC, Duttenhaver JR.

Ann Surg. 1987 Dec;206(6):694-8.PMID: 3689006 [PubMed - indexed for MEDLINE]Related articlesFree article